| Dr John Gregory Baden, MD | |
|
9601 Baptist Health Dr, Suite 1100, Little Rock, AR 72205-6321 | |
| (501) 748-3222 | |
| (501) 227-9151 |
| Full Name | Dr John Gregory Baden |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 30 Years |
| Location | 9601 Baptist Health Dr, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447204284 | NPI | - | NPPES |
| 139805001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | E0901 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Baptist Health Medical Center North Little Rock | North little rock, AR | Hospital |
| Baptist Health Medical Center Heber Spings | Heber springs, AR | Hospital |
| Baptist Health Medical Center- Conway | Conway, AR | Hospital |
| Baptist Health Medical Center-stuttgart | Stuttgart, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Consultants Of Little Rock, Pa | 6103716303 | 65 |
News Archive
Are our bodies vulnerable to some pollutants whose lack of solubility in water, or "hydrophobicity," has always been thought to protect us from them? New Tel Aviv University research has discovered that this is indeed the case.
MicroPhage announced that it has submitted human data from a pivotal clinical study of its ‘Microphage MRSA/MSSA Blood Culture Test' to support a U.S. Food and Drug Administration (FDA) 510(k) premarket notification process. The first of MicroPhage's instrument-free, rapid tests is based on the Company's patented Bacteriophage Amplification platform technology. MicroPhage further announced that it has already begun OUS commercial shipments of the test.
In the study, published on the preprint server bioRxiv, the team evaluated the ability of AS03, CpG 1018 formulated in Alum, the TLR-7 agonist adsorbed to Alum (AS37), the squalene-in-water emulsion (O/W), and Alum to boost protective immunity against SARS-CoV-2.
Researchers at Loma Linda University Health found that walnuts can be incorporated into the daily diet of healthy elders without having a negative impact on weight gain or weight management.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive preliminary results from its Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
› Verified 3 days ago
| Entity Name | Radiology Consultants Of Little Rock, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639124118 PECOS PAC ID: 6103716303 Enrollment ID: O20040319000789 |
News Archive
Are our bodies vulnerable to some pollutants whose lack of solubility in water, or "hydrophobicity," has always been thought to protect us from them? New Tel Aviv University research has discovered that this is indeed the case.
MicroPhage announced that it has submitted human data from a pivotal clinical study of its ‘Microphage MRSA/MSSA Blood Culture Test' to support a U.S. Food and Drug Administration (FDA) 510(k) premarket notification process. The first of MicroPhage's instrument-free, rapid tests is based on the Company's patented Bacteriophage Amplification platform technology. MicroPhage further announced that it has already begun OUS commercial shipments of the test.
In the study, published on the preprint server bioRxiv, the team evaluated the ability of AS03, CpG 1018 formulated in Alum, the TLR-7 agonist adsorbed to Alum (AS37), the squalene-in-water emulsion (O/W), and Alum to boost protective immunity against SARS-CoV-2.
Researchers at Loma Linda University Health found that walnuts can be incorporated into the daily diet of healthy elders without having a negative impact on weight gain or weight management.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive preliminary results from its Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Gregory Baden, MD 9601 Baptist Health Dr, Suite 1100, Little Rock, AR 72205-6321 Ph: (501) 748-3222 | Dr John Gregory Baden, MD 9601 Baptist Health Dr, Suite 1100, Little Rock, AR 72205-6321 Ph: (501) 748-3222 |
News Archive
Are our bodies vulnerable to some pollutants whose lack of solubility in water, or "hydrophobicity," has always been thought to protect us from them? New Tel Aviv University research has discovered that this is indeed the case.
MicroPhage announced that it has submitted human data from a pivotal clinical study of its ‘Microphage MRSA/MSSA Blood Culture Test' to support a U.S. Food and Drug Administration (FDA) 510(k) premarket notification process. The first of MicroPhage's instrument-free, rapid tests is based on the Company's patented Bacteriophage Amplification platform technology. MicroPhage further announced that it has already begun OUS commercial shipments of the test.
In the study, published on the preprint server bioRxiv, the team evaluated the ability of AS03, CpG 1018 formulated in Alum, the TLR-7 agonist adsorbed to Alum (AS37), the squalene-in-water emulsion (O/W), and Alum to boost protective immunity against SARS-CoV-2.
Researchers at Loma Linda University Health found that walnuts can be incorporated into the daily diet of healthy elders without having a negative impact on weight gain or weight management.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive preliminary results from its Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
› Verified 3 days ago
Jeremiah James Sabado, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Childrens Way # 104, Little Rock, AR 72202 Phone: 501-364-1175 Fax: 501-364-1513 | |
Dr. Jamie D Ireland, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4300 West 7th Street, John L. Mcclellan Memorial Veterans Hospital, Little Rock, AR 72205 Phone: 501-257-6615 | |
Dr. Aaron L. Janos, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 South University Avenue, Suite 101, Little Rock, AR 72205 Phone: 501-664-3914 Fax: 501-664-5246 | |
Whitney Goodwin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9601 Baptist Health Dr, Suite 1100, Little Rock, AR 72205 Phone: 501-748-3214 Fax: 501-227-9151 | |
Dr. Uma Mahesh Matapathi, M.D Radiology Medicare: Medicare Enrolled Practice Location: 1 Childrens Way # 104, Little Rock, AR 72202 Phone: 501-364-1100 Fax: 501-364-4082 | |
Dr. Robert L Stuckey Jr., M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 9601 Baptist Health Dr, Suite 1100, Little Rock, AR 72205 Phone: 501-748-3214 Fax: 501-227-9151 | |
Jodi M Barboza, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 S University Ave, Suite 101, Little Rock, AR 72205 Phone: 501-664-3914 Fax: 501-664-5246 |